Alton B. Kremer, VP, Clinical Research at PROGENICS PHARMACEUTICALS INC (PGNX), sold 8,000 shares at $27.63 ($221K) on 2006-01-30, disclosed to the SEC on 2006-02-01.
Open-market sale of $221k PGNX by VP, Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.